Skip Navigation

Cardiovascular Research 2003 57(3):834-842; doi:10.1016/S0008-6363(02)00787-3
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pislaru, S. V
Right arrow Articles by Van de Werf, F. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pislaru, S. V
Right arrow Articles by Van de Werf, F. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs

Sorin V Pislarua, Marc Van Ransta, Cristina Pislarua, Zsolt Szelida, Gregor Theilmeiera, J.M Ossewaardeb, Paul Holvoeta, Stefan Janssensa, Erik Verbekena and Frans J Van de Werfa,*

aUniversity of Leuven, Leuven, Belgium
bThe National Institute for Public Health and The Environment, Bilthoven, The Netherlands

frans.vandewerf{at}uz.kuleuven.ac.be

* Corresponding author. U.Z. Gasthuisberg, Department of Cardiology, Herestraat 49, B-3000 Leuven, Belgium. Tel.: +32-16-343-471; fax: +32-16-343-467.

Objectives: We evaluated the role of intracoronary, intrapulmonary and macrophage-mediated delivery of C. pneumoniae (Cp) on coronary lesion formation. Methods: Pigs were allocated to one of three coronary protocols (intracoronary, macrophage or control groups) or to a fourth—a pulmonary group. In the intracoronary group Cp was injected into the wall of the left anterior descending (LAD) and right coronary arteries (RCA) and vehicle into the circumflex (CX). In the macrophage group autologous macrophages preincubated with Cp or not were injected into the LAD and CX wall, respectively. Animals in the control group received vehicle in LAD and CX. In the pulmonary group aerosolised Cp was given intrabronchially, after a single injection of vehicle into the LAD wall. Delivery into the coronary artery wall was performed with a balloon catheter with low-profile injector ports. Results: Seroconversion occurred in the following proportions: 5/6 (intracoronary group), 4/5 (macrophage group), 0/6 (control group), and 1/6 (intrapulmonary group). Significantly higher maximal intimal thickness (MIT) was observed in LADs of intracoronary and pulmonary groups when compared to corresponding CXs. The presence of Cp antigen was associated with higher MIT (r=0.73; P<0.0001). Injection of macrophages into the coronary artery wall did not induce proliferation. Arteries without coronary interventions were morphologically normal. Conclusions: Intracoronary and intrapulmonary but not macrophage-mediated Cp inoculation were associated with moderate intimal proliferation in the absence of a lipid-rich diet. Pre-existing coronary lesions seem a prerequisite for Cp-induced proliferation.

KEYWORDS Atherosclerosis; Coronary disease; Infection/inflammation; Macrophages


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
A. R. Chade, X. Zhu, R. Lavi, J. D. Krier, S. Pislaru, R. D. Simari, C. Napoli, A. Lerman, and L. O. Lerman
Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease
Circulation, February 3, 2009; 119(4): 547 - 557.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A.D. Hauer, P. de Vos, N. Peterse, H. ten Cate, Th.J.C. van Berkel, F.R.M. Stassen, and J. Kuiper
Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice
Cardiovasc Res, January 1, 2006; 69(1): 280 - 288.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Yang, D. Coriolan, K. Schultz, D. T. Golenbock, and D. Beasley
Toll-Like Receptor 2 Mediates Persistent Chemokine Release by Chlamydia pneumoniae-Infected Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2308 - 2314.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
M. Cochrane, P. Walker, H. Gibbs, and P. Timms
Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque
Microbiology, July 1, 2005; 151(7): 2285 - 2290.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. D. de Kruif, E. C.M. van Gorp, T. T. Keller, J. M. Ossewaarde, and H. ten Cate
Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research
Cardiovasc Res, February 1, 2005; 65(2): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. V. Pislaru and F. Van de Werf
Antibiotic Therapy for Coronary Artery Disease: Can a WIZARD Change It All?
JAMA, September 17, 2003; 290(11): 1515 - 1516.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.